The Latest Breaking News from BNTX

BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapies against cancer. 

Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) omicron-targeted COVID-19 vaccine is delayed by several weeks due to a slower-than-expected data gathering process, 

Someone with a lot of money to spend has taken a bearish stance on BioNTech (NASDAQ:BNTX). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have 

If history is any guide, there may be trouble ahead for shares of BioNTech (NASDAQ:BNTX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

With COVID-19 mutating into newer, more transmissible variants, biotechnology stocks have the potential to again outperform as authorities worldwide redouble their efforts at mass vaccinations. So, we think it could be wise to now add quality biotech stocks Vertex Pharmaceuticals (VRTX), BioNTech SE (BNTX), and Incyte (INCY) to one’s watchlist.…

A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades.

Shares of vaccine makers, including Moderna Inc (NASDAQ: MRNA), BioNTech SE - ADR (NASDAQ: BNTX) and Novavax, Inc.

Within the last quarter, BioNTech (NASDAQ:BNTX) has observed the following analyst ratings: